Publication | Open Access
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
29
Citations
35
References
2018
Year
ClinicalTrials.gov Identifier: NCT01827943 (trial registration date: October 29, 2012); Retrospectively registered.
| Year | Citations | |
|---|---|---|
Page 1
Page 1